Predicting the Safety and Effectiveness of Inferior Vena Cava Filters

The PRESERVE Trial is the first large-scale, multi-specialty, prospective clinical study to evaluate the use of inferior vena cava (IVC) filters and related follow-up treatment in the United States.

It is sponsored by IVC Filter Study Group Foundation, which is a joint collaboration between the Society of Interventional Radiology (SIR) and the Society for Vascular Surgery (SVS).

Learn More

The Latest from PRESERVE


PRESERVE presented by Matthew Johnson, MD on 17/Mar/2018 at the Society for Intervention Radiology (SIR) meeting and by David Gillespie, MD on 22/Jun/2018 at the Vascular Annual Meeting (VAM).


As of August 2018, four manufacturers have reached their 300 filter patient enrollment cap.


If you are considering participating or already enrolled in PRESERVE »

Important information about PRESERVE.